Detail práce

Social and Medical Costs of Dupuytren's Desease

Autor: Bc. Jakub Losenický
Rok: 2014 - letní
Vedoucí: PhDr. Jana Votápková
Konzultant:
Typ práce: Bakalářská
Jazyk: Anglicky
Stránky: 75
Ocenění: Pochvala děkana Fakulty sociálních věd za vynikající výkon u státních zkoušek a za vynikající bakalářskou práci.
Odkaz: https://is.cuni.cz/webapps/zzp/detail/138405/
Abstrakt: The thesis investigates the relative cost-effectiveness of two treatment methods of Dupuytren's disease
(DD) - surgical fasciectomy and injectable collagenase - and assesses the impact of the two health
technologies on the budget of the Czech Republic. For this purpose, cost-minimization analysis (CMA)
and budget impact analysis (BIA) are employed and, importantly, both social and medical costs are
taken into consideration. Concerning the CMA, different patients are modelled with respect to personal
characteristics such as occupation, type of work (manual, non-manual) and income. In the BIA, data on
DD occurrence in the Czech Republic from the National Register of Hospitalised Patients (NRHOSP)
are analysed. We found that collagenase is a cost-minimizing treatment for a big majority of employees
and manually working SMEs. On the other hand, collagenase turned out to be more expensive than
fasciectomy for most of the non-manual SMEs. All things considered, collagenase appeared to be
cheaper for most of the model patients. We also discovered that if all the patients in the dataset were
treated with collagenase, the Czech state budget would annually save 1,685,452 CZK. The average
annual costs of fasciectomy and collagenase were 41,334,049 CZK and 39,648,597 CZK, respectively
Prosinec 2017
poútstčtsone
    123
45678910
11121314151617
18192021222324
25262728293031

Partneři

ČSOB
Deloitte
McKinsey & Company

Sponzoři

CRIF